Glucocerebrosidase gene and severity of motor decline in newly diagnosed Parkinson’s disease

Takeaway

  • People carrying glucocerebrosidase gene variants have more severe motor disease impairment following diagnosis of Parkinson’s disease.

Why this matters ?

    To date, few studies have investigated the effect of glucocerebrosidase gene carrier status on motor decline in early phases of Parkinson’s disease. These novel findings reveal important clinical features of glucocerebrosidase gene-associated Parkinson’s disease, which could help to improve both individualized management and clinical trial design.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.